- Matthew Hoffman, MD Principle Investigator
- Anthony Sciscione, DO Principle Investigator
- Stephanie Lynch Research Nurse Manager
Research Nurse Coordinators
Our practice is involved in the following research studies. All of these studies are sponsored by the National Institute for Health:
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)Purpose - This study aims to screen pregnant women in the first half of pregnancy for recent primary CMV infection and evaluate in a proper randomized clinical trial whether maternal administration of CMV hyperimmune globulin will prevent congenital CMV infection. Qualifications - You must be less than 14 weeks pregnant and never given birth to a baby. Benefits - Participation may help doctors in the future find better treatments for mothers and babies. Participants will receive a modest compensation to reimburse them for time required to participate.
An Observational Study of Hepatitis C Virus in Pregnancy (HCV)Purpose - This observational study will allow a better understanding of HCV in pregnancy and will review the clinical and laboratory predictors of the risk of transmission to the fetus and newborn. Qualifications - Singleton pregnancy. Positive HCV antibody screen. Gestational age at screening no later than 23 weeks and 6 days and gestational age at enrollment no later than 27 weeks and 6 days. Benefits - Participation may help doctors in the future find better treatments for mothers and babies. Participants will receive a modest compensation to reimburse them for time required to participate.
ALPSThe rate of pre-term birth has steadily increased in the US over the past 10 years. Late preterm infants experience a higher rate of readmission than their counterparts, and these infants are more likely to suffer complications such as respiratory distress, kernicterus, feeding difficulties, and hypoglycemia. The study is randomized, double masked, placebo-controlled clinical trial. This study would like to enroll 2800 women with singletons pregnancies who are likely to delivery between 34 0/7 and 36 0/7 weeks gestation nationwide. The purpose of the study is to evaluate whether antenatal corticosteroids can decrease the rate of neonatal respiratory support, thus decreasing NICU admissions for late preterm infants.
Occasionally there are incentives for individuals to participate in research studies. These incentives may be financial incentives or the incentive of having more ultrasounds (free of charge) than you would normally have during your pregnancy. If you would like to find out if you qualify to participate in any of the research studies please contact the research coordinator:
- Phone: (302) 733-3576
- Study Pager: (302) 573-7413
- Email: email@example.com